“…Nevertheless, CAF different subtypes with heterogeneous biological properties make distinct functional contributions (Tab. 3) (Chang et al, 2002;Orimo and Weinberg, 2007;Radisky et al, 2007;Zeisberg et al, 2007;Potenta et al, 2008;Council and Hameed, 2009;Kalluri and Weinberg, 2009;Spaeth et al, 2009;Wikström et al, 2009;Toullec et al, 2010;Bochet et al, 2013;Jia et al, 2013;Kim et al, 2015;Shiga et al, 2015;Kalluri, 2016;Öhlund et al, 2017;Bartoschek et al, 2018;Gunaydin, 2021;Helms et al, 2021). CAFs secrete a considerable variety of autocrine and paracrine cytokines and other tumor-promoting factors so as to modulate the TME primarily embodied in the aspects of cancer-elicited inflammation, angiogenesis, cancer cell proliferation, invasion, migration, metastasis, therapeutic resistance, etc.…”